Neel K. Gupta

1.9k total citations
17 papers, 247 citations indexed

About

Neel K. Gupta is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Neel K. Gupta has authored 17 papers receiving a total of 247 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 9 papers in Oncology and 4 papers in Genetics. Recurrent topics in Neel K. Gupta's work include Lymphoma Diagnosis and Treatment (11 papers), CAR-T cell therapy research (5 papers) and CNS Lymphoma Diagnosis and Treatment (4 papers). Neel K. Gupta is often cited by papers focused on Lymphoma Diagnosis and Treatment (11 papers), CAR-T cell therapy research (5 papers) and CNS Lymphoma Diagnosis and Treatment (4 papers). Neel K. Gupta collaborates with scholars based in United States, Switzerland and India. Neel K. Gupta's co-authors include Patrick Treseler, Gabriel N. Mannis, James L. Rubenstein, Amanda K. LaMarre, Erin Reid, Lawrence D. Kaplan, Lauren S. Maeda, Charalambos Andreadis, Dita Gratzinger and Debra K. Czerwinski and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Neel K. Gupta

16 papers receiving 246 citations

Peers

Countries citing papers authored by Neel K. Gupta

Since Specialization

Citations

This map shows the geographic impact of Neel K. Gupta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neel K. Gupta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neel K. Gupta more than expected).

Fields of papers citing papers by Neel K. Gupta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neel K. Gupta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neel K. Gupta. The network helps show where Neel K. Gupta may publish in the future.

Co-authorship network of co-authors of Neel K. Gupta

This figure shows the co-authorship network connecting the top 25 collaborators of Neel K. Gupta. A scholar is included among the top collaborators of Neel K. Gupta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neel K. Gupta. Neel K. Gupta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Shared Decision-making Lowers Medical Expenditures and the Effect Is Amplified in Racially-Ethnically Concordant Relationships 2023 ·Medical Care ·Timothy A. Brown, (unknown), Hector P. Rodríguez, (unknown), Neel K. Gupta, (unknown), (unknown), Sofía Valenzuela	6
2	CD20-Targeted Therapy Ablates De Novo Antibody Response to Vaccination but Spares Preestablished Immunity 2022 ·Blood Cancer Discovery ·Tanaya Shree, Vishnu Shankar, (unknown), Debra K. Czerwinski, Joseph G. Schroers‐Martin, (unknown), Sara Beygi, (unknown), (unknown), (unknown), David M. Kurtz, Michael S. Khodadoust, Neel K. Gupta, Lauren S. Maeda, Ranjana H. Advani, Ash A. Alizadeh, Ronald Levy	27
3	Lisocabtagene maraleucel (liso-cel) as second-line (2L) therapy for R/R large B-cell lymphoma (LBCL) in patients (pt) not intended for hematopoietic stem cell transplantation (HSCT): Primary analysis from the phase 2 PILOT study. 2022 ·Journal of Clinical Oncology ·Alison R. Sehgal, Daanish Hoda, Peter A. Riedell, Nilanjan Ghosh, Mehdi Hamadani, Gerhard Hildebrandt, John E. Godwin, Patrick M. Reagan, Nina D. Wagner‐Johnston, James Essell, Rajneesh Nath, Scott R. Solomon, (unknown), Edward Licitra, Suzanne Fanning, Neel K. Gupta, Ronald L. Dubowy, (unknown), Lei Wang, Leo I. Gordon	3
4	Clinical and radiographic assessment of post-treatment endodontic disease by primary healthcare professionals: A hospital-based 1-year follow-up 2022 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Neel K. Gupta, (unknown), (unknown), (unknown)	3
5	Stage I–II diffuse large B-cell lymphoma treated with rituximab and chemotherapy with or without radiotherapy 2021 ·Leukemia & lymphoma ·Michael S. Binkley, Susan M. Hiniker, (unknown), Christopher H. Yoo, (unknown), Michael C. Jin, H. Henry Guo, Neel K. Gupta, Yasodha Natkunam, Ranjana H. Advani, Richard T. Hoppe	0
6	Role of FNA with core biopsy or cell block in patients with nodular lymphocyte‐predominant Hodgkin lymphoma 2020 ·Cancer Cytopathology ·(unknown), Steven Long, Yasodha Natkunam, Christina S. Kong, Neel K. Gupta, Dita Gratzinger	11
7	Prediction of therapeutic outcomes in DLBCL from circulating tumor DNA dynamics. 2016 ·Journal of Clinical Oncology ·David M. Kurtz, Florian Scherer, Aaron M. Newman, Alexander Craig, Michael S. Khodadoust, Alexander F. Lovejoy, Daniel M. Klass, Jacob J. Chabon, Cynthia Glover, Li Zhou, Chih Long Liu, Neel K. Gupta, Lauren S. Maeda, Ranjana H. Advani, Ronald Levy, Maximilian Diehn, Ash A. Alizadeh	4
8	Long-term survival in AIDS-related primary central nervous system lymphoma 2016 ·Neuro-Oncology ·Neel K. Gupta, Amber Nolan, Antonio Omuro, Erin Reid, (unknown), Gabriel N. Mannis, Michael Jaglal, Julio C. Chávez, P Rubinstein, A. Clark Griffin, Donald I. Abrams, Jimmy Hwang, Lawrence D. Kaplan, Judith Luce, Paul A. Volberding, Patrick Treseler, James L. Rubenstein	38
9	Absence of Evidence Implicating Hematopoietic Stem Cells As Common Progenitors for DLBCL Mutations 2016 ·Blood ·Max Jan, Florian Scherer, David M. Kurtz, Aaron M. Newman, Henning Stehr, Chih Long Liu, Li Zhou, Cynthia Glover, Ranjana H. Advani, Lauren S. Maeda, Neel K. Gupta, Ronald Levy, Christian A. Kunder, Isidro Sánchez‐García, Maximilian Diehn, Ash A. Alizadeh	1
10	Phase I/II Clinical Trial of CpG-Activated Whole Cell Vaccine in Mantle Cell Lymphoma (MCL): Results in Safety and Efficacy from Planned Interim Analysis 2015 ·Blood ·Michael P. Chu, Joshua Brody, Holbrook E. Kohrt, Matthew J. Frank, Michael S. Khodadoust, Sunil Reddy, Ranjana H. Advani, Neel K. Gupta, Ginna G. Laport, Lauren S. Maeda, Everett Meyer, David B. Miklos, Robert S. Negrin, Andrew R. Rezvani, Wen‐Kai Weng, Kevin Sheehan, Malek Faham, Debra K. Czerwinski, Ami Okada, Ronald Levy	3
11	New Meets Old: A Case Study and Review of Novel Therapeutics for the Treatment of CLL in Older Patients 2014 ·Journal of the National Comprehensive Cancer Network ·Neel K. Gupta, Charalambos Andreadis	3
12	High-Dose Methotrexate Is Effective, Safe, and Leads To Durable Responses In Patients With AIDS-Related Primary Central Nervous System Lymphoma Treated During The Era Of Combined Anti-Retroviral Therapy 2013 ·Blood ·Neel K. Gupta, Jimmy J. Hwang, James L. Rubenstein	1
13	How I treat CNS lymphomas 2013 ·Blood ·James L. Rubenstein, Neel K. Gupta, Gabriel N. Mannis, Amanda K. LaMarre, Patrick Treseler	123
14	Outcome of patients with relapsed/refractory acquired immune deficiency syndrome-related lymphoma diagnosed 1999–2008 and treated with curative intent in the AIDS Malignancy Consortium 2012 ·Leukemia & lymphoma ·Ulas D. Bayraktar, Juan Carlos Ramos, Adam M. Petrich, Neel K. Gupta, Shelly Lensing, Page C. Moore, Erin Reid, David M. Aboulafia, Lee Ratner, Ronald T. Mitsuyasu, Timothy P. Cooley, David H. Henry, Paul M. Barr, Ariela Noy	17
15	An unusual cause of acute obstructive jaundice in an HIV-infected patient 2011 ·International Journal of STD & AIDS ·Neel K. Gupta, (unknown), C A Bowman	3
16	Rituximab Fails to Reduce Histologic Transformation (HT) Rate of Follicular Lymphoma (FL) to Diffuse Large B-Cell Lymphoma (DLBCL) 2008 ·Blood ·Ariel E. Marciscano, Neel K. Gupta, Zhigang Zhang, Julie Teruya‐Feldstein, Ariela Noy	2
17	Laryngeal sarcoidosis. 2008 ·PubMed ·Enrique Palacios, Andrew Smith, Neel K. Gupta	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact